Browse by Title

Type here to filter the list

Q
QSP in the era of ML
Favorite

Ioannis (Yannis) Androulakis, PhD – Rutgers University ### 2380007###Speaker###Professor###Rutgers University###
Speaker: Ioannis (Yannis) Androulakis, PhD – Rutgers University
###
QSP Modeling and Dose Optimization: A Regulatory Perspective
Favorite

Atiqur Rahman, PhD – FDA ### 2360685###Speaker###Division Director###FDA###
Speaker: Atiqur Rahman, PhD – FDA
###
QSP modeling of engineered autologous T-cell therapies: random virtual patients vs virtual twins
Favorite

Oleg Demin Jr (he/him/his) – InSysBio CY ### 2360667###Speaker###Scientific Director, Oncology & Immuno-Oncology Quantitative Systems Pharmacology###InSysBio CY###
Speaker: Oleg Demin Jr (he/him/his) – InSysBio CY
### he/him/his
QSP SIG Event: Strategies for Successful Application of QSP Platform Models for Clinical Development and Regulatory Engagement
Favorite

Steven Chang, n/a – Simulations Plus, Inc. ### 2457731###Chair######Simulations Plus, Inc.###
Chair: Steven Chang, n/a – Simulations Plus, Inc.
### @@@ Weirong Wang, PhD – J&J Innovative Medicine ### 2457505###Chair######J&J Innovative Medicine###
Chair: Weirong Wang, PhD – J&J Innovative Medicine
### @@@ Brian Schmidt ### 2407942###Chair#########
Chair: Brian Schmidt
### @@@ Mengdi Tao, n/a – Sanofi US ### 2454043###Speaker###Senior Scientist###Sanofi US###
Speaker: Mengdi Tao, n/a – Sanofi US
### @@@ Alexander Ratushny – Bristol Myers Squibb ### 2453806###Speaker###Senior Director###Bristol Myers Squibb###
Speaker: Alexander Ratushny – Bristol Myers Squibb
### @@@ Rohit Rao, PhD – Pfizer ### 2453967###Speaker###Quantitative Systems Pharmacologist###Pfizer###
Speaker: Rohit Rao, PhD – Pfizer
### @@@ Iraj Hosseini, Distinguished Scientist/Group Head/Pharmacology Team Leader – Genentech ### 2360734###Speaker###Distinguished Scientist###Genentech###
Speaker: Iraj Hosseini, Distinguished Scientist/Group Head/Pharmacology Team Leader – Genentech
### @@@ Richard Allen, PhD – Pfizer ### 2360668###Speaker###Research Fellow and Quantitative Systems Pharmacology Lead###Pfizer###
Speaker: Richard Allen, PhD – Pfizer
### @@@ Jin Jin, PhD (she/her/hers) – Genentech, Inc. ### 2407911###Panelist###Executive Director and Senior Fellow###Genentech, Inc.###
Panelist: Jin Jin, PhD (she/her/hers) – Genentech, Inc.
### she/her/hers @@@ Lourdes Cucurull-Sanchez, PhD MPhil (she/her/hers) – Pharmetheus ### 2380006###Panelist###Platform Scientific Lead###Pharmetheus###
Panelist: Lourdes Cucurull-Sanchez, PhD MPhil (she/her/hers) – Pharmetheus
### she/her/hers @@@ Susana Zaph, PhD (she/her/hers) – Sanofi ### 2360669###Panelist###Senior Director & Head of Translational Disease Modeling - US###Sanofi###
Panelist: Susana Zaph, PhD (she/her/hers) – Sanofi
### she/her/hers
Case application vignettes of QSP platform models informed by clinical data
Favorite

Mengdi Tao, n/a – Sanofi US ### 2454043###Speaker###Senior Scientist###Sanofi US###
Speaker: Mengdi Tao, n/a – Sanofi US
### @@@ Alexander Ratushny – Bristol Myers Squibb ### 2453806###Speaker###Senior Director###Bristol Myers Squibb###
Speaker: Alexander Ratushny – Bristol Myers Squibb
### @@@ Rohit Rao, PhD – Pfizer ### 2453967###Speaker###Quantitative Systems Pharmacologist###Pfizer###
Speaker: Rohit Rao, PhD – Pfizer
### @@@ Iraj Hosseini, Distinguished Scientist/Group Head/Pharmacology Team Leader – Genentech ### 2360734###Speaker###Distinguished Scientist###Genentech###
Speaker: Iraj Hosseini, Distinguished Scientist/Group Head/Pharmacology Team Leader – Genentech
###
Quantitative clinical pharmacology of antibody drug conjugate development: challenges and opportunities
Favorite

Yan Feng, PhD (she/her/hers) – Genmab ### 2360700###Chair###Senior Director###Genmab###
Chair: Yan Feng, PhD (she/her/hers) – Genmab
### she/her/hers @@@ Shelly Wang, PhD (she/her/hers) – Gilead Sciences ### 2360661###Chair###Principal Scientist II###Gilead Sciences###
Chair: Shelly Wang, PhD (she/her/hers) – Gilead Sciences
### she/her/hers @@@ Katharina Wilkins, PhD (she/her/hers) – Metrum Research Group ### 2360701###Speaker###Group leader, Principal scientist I, Translational and Systems Pharmacology###Metrum Research Group###
Speaker: Katharina Wilkins, PhD (she/her/hers) – Metrum Research Group
### she/her/hers @@@ Rudy Gunawan, PhD – Pfizer ### 2360702###Speaker###Director, Pharmacometrics & System Pharmacology###Pfizer###
Speaker: Rudy Gunawan, PhD – Pfizer
### @@@ Yangbing Li, PhD – U.S. Food and Drug Administration ### 2408373###Speaker###Senior Reviewer###U.S. Food and Drug Administration###
Speaker: Yangbing Li, PhD – U.S. Food and Drug Administration
###
Quantitative Pharmacology Approach to Inform the Bench-to-Bed Translation of CRSPR-Based in-vivo Gene Editing Therapy across Multiple Development Phases
Favorite

Ahmed Abdelhady Abozeid, PhD (he/him/his) – Intellia ### 2407052###Speaker###Clinical Pharmacology Director###Intellia###
Speaker: Ahmed Abdelhady Abozeid, PhD (he/him/his) – Intellia
### he/him/his
Quantitative Pharmacology Considerations in the Development of Cell Therapies - Opportunities & Challenges
Favorite

Hardik Mody, PhD (he/him/his) – Genentech ### 2363736###Speaker###Principal Scientist, Clinical Pharmacology###Genentech###
Speaker: Hardik Mody, PhD (he/him/his) – Genentech
### he/him/his
Quantitative Pharmacology Principles and Model-Informed Development Approaches for RNAi Therapeutics
Favorite

Vivaswath S. Ayyar, PhD – J&J Innovative Medicine ### 2363739###Speaker###Associate Scientific Director###J&J Innovative Medicine###
Speaker: Vivaswath S. Ayyar, PhD – J&J Innovative Medicine
###
Quantitative Systems Pharmacology in Late Stage Oncology Drug Development– New Horizons to Dose Optimization
Favorite

Piet van der Graaf, PharmD, PhD – Certara ### 2360684###Chair###Senior Vice President###Certara###
Chair: Piet van der Graaf, PharmD, PhD – Certara
### @@@ Amitava Mitra, PhD – Clinical Pharmacology ### 2360683###Chair and Speaker###Executive DIrector###Clinical Pharmacology###
Chair and Speaker: Amitava Mitra, PhD – Clinical Pharmacology
### @@@ Tommy Li, PhD – Genmab ### 2360686###Speaker###Director###Genmab###
Speaker: Tommy Li, PhD – Genmab
### @@@ Atiqur Rahman, PhD – FDA ### 2360685###Speaker###Division Director###FDA###
Speaker: Atiqur Rahman, PhD – FDA
###
Quantitative Systems Pharmacology Modeling to Inform Preclinical-to-Clinical Translation of T-cell Engager Programs
Favorite

Colin W. Castleberry, PhD (he/him/his) – Amgen ### 2446207###Speaker###Senior Scientist###Amgen###
Speaker: Colin W. Castleberry, PhD (he/him/his) – Amgen
### he/him/his